Therapeutic drug monitoring in pediatric renal transplantation.

about

Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS.Limustin®, a non-innovator tacrolimus formulation, yields reduced drug exposure in pediatric renal transplant recipients.

P2860

Q40324683-1996340C-55FC-47A5-BB6F-8996D81BB261 Q51797706-1098C556-A750-4F16-A001-6DB371F78A11

P2860

Therapeutic drug monitoring in pediatric renal transplantation.

Item

http://www.wikidata.org/entity/Q38206952

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic drug monitoring in pediatric renal transplantation.

@en

type

Item

label

Therapeutic drug monitoring in pediatric renal transplantation.

@en

prefLabel

Therapeutic drug monitoring in pediatric renal transplantation.

@en

P1476

Therapeutic drug monitoring in pediatric renal transplantation.

@en

P2093

Lutz T Weber

http://www.w3.org/2001/XMLSchema#string

P2860

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.

Clinical pharmacokinetics of everolimus.

High-throughput analysis of everolimus (RAD001) and cyclosporin A (CsA) in whole blood by liquid chromatography/mass spectrometry using a semi-automated 96-well solid-phase extraction system.

Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Pharmacogenetics: the therapeutic drug monitoring of the future?

Review: therapeutic drug monitoring in pediatrics.

Patient management by Neoral C(2) monitoring: an international consensus statement.

P2888

s00467-014-2813-8

P304

253-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-014-2813-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047748574

http://www.w3.org/2001/XMLSchema#string

P698

24763544

http://www.w3.org/2001/XMLSchema#string

Therapeutic drug monitoring in pediatric renal transplantation.

about

P2860

P2860

Therapeutic drug monitoring in pediatric renal transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698